2014 | FDG-PET predicts outcomes of treated bone metastasis following palliative radiotherapy in patients with hepatocellular carcinoma | LIVER INTERNATIONAL |
2014 | Feasibility and Outcomes of Hypofractionated Simultaneous Integrated Boost-Intensity Modulated Radiotherapy for Malignant Gliomas: A Preliminary Report
| YONSEI MEDICAL JOURNAL |
2019 | Feasibility of hybrid TomoHelical- and TomoDirect-based volumetric gradient matching technique for total body irradiation
| RADIATION ONCOLOGY |
2020 | Feasibility of single vocal cord irradiation as a treatment strategy for T1a glottic cancer | HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK |
2013 | Feasibility of Sorafenib Combined with Local Radiotherapy in Advanced Hepatocellular Carcinoma
| YONSEI MEDICAL JOURNAL |
2015 | Feasibility of using Geant4 Monte Carlo simulation for IMRT dose calculations for the Novalis Tx with a HD-120 multi-leaf collimator | JOURNAL OF THE KOREAN PHYSICAL SOCIETY |
2016 | Feasibility Study of a Custom-made Film for End-to-End Quality Assurance Test of Robotic Intensity Modulated Radiation Therapy System
| Korean Journal of Medical Physics (의학물리) |
2015 | Feasibility Study of the Neutron Dose for Real-time Image-guided Proton Therapy: A Monte Carlo Study | JOURNAL OF THE KOREAN PHYSICAL SOCIETY |
2015 | Fibroblast growth factor receptor 1 gene amplification is associated with poor survival in patients with resected esophageal squamous cell carcinoma.
| ONCOTARGET |
2020 | First Experience in Korea of Stereotactic Partial Breast Irradiation for Low-Risk Early-Stage Breast Cancer
| FRONTIERS IN ONCOLOGY |
2020 | Flexible film dosimeter for in vivo dosimetry | MEDICAL PHYSICS |
2016 | Focal exposure of limited lung volumes to high-dose irradiation down-regulated organ development-related functions and up-regulated the immune response in mouse pulmonary tissues.
| BMC GENETICS |
2002 | Fractionated High-Dose-Rate Brachytherapy in the Management of Uterine Cervical Cancer
| YONSEI MEDICAL JOURNAL |
2014 | Full-dose gemcitabine is a more effective chemotherapeutic agent than 5-fluorouracil for concurrent chemoradiotherapy as first-line treatment in locally advanced pancreatic cancer | CHEMOTHERAPY |
2015 | Gamma Evaluation Combined with Isocenter Optimal Matching in Intensity Modulated Radiation Therapy Quality Assurance | JOURNAL OF THE KOREAN PHYSICAL SOCIETY |
2011 | Gastroduodenal complications after concurrent chemoradiation therapy in patients with hepatocellular carcinoma: endoscopic findings and risk factors | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2013 | Gastrointestinal hemorrhage after concurrent chemoradiotherapy in locally advanced pancreatic cancer
| GUT AND LIVER |
2013 | Gemcitabine based neoadjuvant chemoradiotherapy therapy in patients with borderline resectable pancreatic cancer | PANCREATOLOGY |
2005 | Gemcitabine monotherapy as salvage chemotherapy in heavily pretreated metastatic breast cancer | BREAST CANCER RESEARCH AND TREATMENT |
2020 | Gene Expression Profiling Identifies Akt as a Target for Radiosensitization in Gastric Cancer Cells
| FRONTIERS IN ONCOLOGY |